TrialNeuro-oncology2021

Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825).

Jeffrey S Wefel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.